Serum miRNAs as potential biomarkers for the bronchiolitis obliterans syndrome after lung transplantation
{{output}}
Lung transplantation (LTx) is the last treatment for patients suffering from end-stage lung diseases. Survival post-LTx is hampered by the development of the bronchiolitis obliterans syndrome (BOS) and diagnosis is often late. Given the urgent clinical need to... ...
